Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

KLINBEFORSK clinical treatment research

Helse Sør-Øst RHF

KLINBEFORSK will contribute to more patients being offered the opportunity to participate in clinical trials and will strengthen the basis for the development of effective and safe high-quality healthcare services. Studies funded through the program will meet needs identified by patients, the service, decision-makers and the researcher themselves.

NB! The announcement of research funding from KLINBEFORSK this year is carried out in a two-stage process.

The application deadline for sketches for the first application stage is May 15, 2025 at 4:00 PM.

The regional health authorities are announcing up to NOK 180 million for national clinical treatment studies. All applications require participation from clinical research communities in all health regions, facilitation of equal access for patients nationally, and user participation.

The call is open to all fields of study , and in addition, the call includes a prioritization of areas where a specific research need has been identified. Prioritization of support for these areas assumes that the applications are otherwise considered worthy of support within the framework of the call after academic assessment as for ordinary applications.

In this year's call, priority is given to the following two areas:

Proton therapy: Proton therapy is being established as a multi-regional treatment service with patient treatment starting in 2025, and there is a great need for more clinical studies in the area.
Rehabilitation: The evaluation of the Escalation Plan for Habilitation and Rehabilitation (2017-2019) has concluded that the field of physical medicine and rehabilitation is a research-poor area with little knowledge about treatment effects. The need for increased knowledge and research in the area is also highlighted in the National Health and Coordination Plan 2024-2027. Clinical studies in the area must have a central anchoring in the specialist health service, but can be carried out with established collaboration with the primary health service. In this way, prioritization can also address issues related to interaction in the services.

This year's call is being conducted as a two-stage process. This means that applicants for research funding from KLINBEFORSK in the first stage must submit an outline application. Based on this outline, selected applicants will be invited to submit a full application in the second stage of the call.

What can be applied for?

KLINBEFORSK supports projects with research funds over a period of up to five years .

The application limit per project is set at NOK 7 - 25 million for the project period.

The project budget must contain detailed information about the cost elements to be justified. The budget must be realistic for the implementation of the project.

All additional costs for the implementation of the research project can be applied for to be covered from the program. However, it is not possible to cover ordinary treatment costs through the project funds. These are assumed to be covered by the hospitals/institutions themselves. Contributions to patient recruitment in studies with international partners are limited to the inclusion of Norwegian patients.

Costs related to the establishment of national research networks may be included as part of the project.

Overview of budget elements

A complete application to KLINBEFORSK must contain a clear and detailed application budget that will be used as a basis for assessing implementation options.

The budget must include an overview of the project's costs with a financing plan that shows the various sources of financing the project has.

In CLINICAL RESEARCH, the following cost elements can be included in the application:

PhD scholarships: Such scholarships shall have a duration equivalent to three full-time equivalents and may be taken out as a 50 – 100% position during the project period. Candidates shall be employed at an eligible institution. The application form in eSøknad states the position share and duration. Please use the form's field for "supplementary information" if there is a need to provide further details for the position. PhD scholarships are awarded as a lump sum and must be stated in the application form as "personnel by rate". The rate amounts to NOK 1,431,000 (for 2026) and consists of salary and social costs as well as a general operating subsidy.
Other scientific positions such as researcher or other research personnel (coordinator, research nurse, etc.) must be entered in the form under "personnel without a rate" where the actual salary costs for the position are stated.
Operating costs for the project, including medicines and study materials. For projects that are part of international collaborations, KLINBEFORSK only covers costs associated with the inclusion of Norwegian patients.
Purchase of services from research support units, including specific infrastructure costs for the implementation of the projects (e.g. monitoring, data management, eCRF solution, etc.).
Costs related to user participation.

Indirect costs related to the institutions' fixed expenses (e.g. rent, electricity, cleaning and administrative support functions, etc.) are not covered by KLINBEFORSK.

KLINBEFORSK does not award funds for postdoctoral positions.

Application requirements

In addition to general application requirements, specific requirements may also be set for applications in the call for applications and in the associated application form for the call for applications in question. Applicants are asked to familiarize themselves with these. Applications that do not meet the formal requirements will be rejected.

The application and all attachments must be written in English.
The project must be led by an eligible institution (cf. the overview of applicant institutions ) with a focus on the institution's research management.
The project must have partners in all four health regions with participants from at least one of the eligible institutions. The partners must be listed in the application form.
Project description is a mandatory attachment and must be submitted according to the template for KLINBEFORSK (max. 10 pages). Other attachments are CVs with a list of publications for the project manager and key collaborators from each of the three other regions (max. 5 pages per participant). Other attachments should not be included in the application and will not be processed further. Please note that applications that do not follow the guidelines and format requirements will be rejected.

Specialties

Clinical Trials

Others

Eligibility Requirements

Applicants must be employed by a health authority or a private, non-profit hospital with access to the regional health authorities' research funds (see list of applicant institutions ). Employees at other private institutions with access to regional research funds cannot apply themselves, but can be participants in the projects. Applications must be anchored in the applicant institution's research management.

The project manager and key partners (at least one per region) must be employed in at least a 20% position at an eligible institution at the time of application and during the entire project period.

A project manager can only submit one application , but can be a collaborative partner in multiple projects.

Project managers who turn 70 at the start of the project are not eligible to apply. If the project manager turns 70 during the project period, the applicant institution must attach a written explanation of the transfer of project management responsibility and how this will be handled.

Eligible Countries:

Norway

Sponsor Details

Sponsor Institute/Organizations: Helse Sør-Øst RHF

Sponsor Type: Corporate/Non-Profit

Address: Parkgata 36 2317 Hamar

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity